201 related articles for article (PubMed ID: 19399471)
21. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.
Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM
Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value and their clinical implication of 89-gene signature in glioma.
Shahid M; Cho KM; Nguyen MN; Choi TG; Jo YH; Aryal SN; Yoo JY; Yun HR; Lee JW; Eun YG; Lee JS; Kang I; Ha J; Yoon HJ; Kim SY; Kim SS
Oncotarget; 2016 Aug; 7(32):51237-51250. PubMed ID: 27323413
[TBL] [Abstract][Full Text] [Related]
23. Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer.
Yu C; Hong H; Lu J; Zhao X; Hu W; Zhang S; Zong Y; Mao Z; Li J; Wang M; Feng B; Sun J; Zheng M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806905. PubMed ID: 30336768
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis.
Creighton CJ; Casa A; Lazard Z; Huang S; Tsimelzon A; Hilsenbeck SG; Osborne CK; Lee AV
J Clin Oncol; 2008 Sep; 26(25):4078-85. PubMed ID: 18757322
[TBL] [Abstract][Full Text] [Related]
25. Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP.
Shen L; O'Shea JM; Kaadige MR; Cunha S; Wilde BR; Cohen AL; Welm AL; Ayer DE
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5425-30. PubMed ID: 25870263
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
27. Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
Qi Y; Chen D; Lu Q; Yao Y; Ji C
Dis Markers; 2019; 2019():3917040. PubMed ID: 31885736
[TBL] [Abstract][Full Text] [Related]
28. p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value.
Santoro A; Vlachou T; Luzi L; Melloni G; Mazzarella L; D'Elia E; Aobuli X; Pasi CE; Reavie L; Bonetti P; Punzi S; Casoli L; Sabò A; Moroni MC; Dellino GI; Amati B; Nicassio F; Lanfrancone L; Pelicci PG
Cell Rep; 2019 Jan; 26(3):624-638.e8. PubMed ID: 30650356
[TBL] [Abstract][Full Text] [Related]
29. FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome.
Wang C; Sample KM; Gajendran B; Kapranov P; Liu W; Hu A; Zacksenhaus E; Li Y; Hao X; Ben-David Y
Front Immunol; 2021; 12():607836. PubMed ID: 33717090
[TBL] [Abstract][Full Text] [Related]
30. A 63 signature genes prediction system is effective for glioblastoma prognosis.
Zhang Y; Xu J; Zhu X
Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
[TBL] [Abstract][Full Text] [Related]
31. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
Arif T; Krelin Y; Shoshan-Barmatz V
Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
[TBL] [Abstract][Full Text] [Related]
32. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
33. PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma.
Ganci F; Pulito C; Valsoni S; Sacconi A; Turco C; Vahabi M; Manciocco V; Mazza EMC; Meens J; Karamboulas C; Nichols AC; Covello R; Pellini R; Spriano G; Sanguineti G; Muti P; Bicciato S; Ailles L; Strano S; Fontemaggi G; Blandino G
Clin Cancer Res; 2020 Jun; 26(12):2956-2971. PubMed ID: 31969334
[TBL] [Abstract][Full Text] [Related]
34. c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients.
Lê MG; Mathieu MC; Douc-Rasy S; Le Bihan ML; Adb El All H; Spielmann M; Riou G
Int J Cancer; 1999 Dec; 84(6):562-7. PubMed ID: 10567899
[TBL] [Abstract][Full Text] [Related]
35. Identifying cancer prognostic modules by module network analysis.
Zhou XH; Chu XY; Xue G; Xiong JH; Zhang HY
BMC Bioinformatics; 2019 Feb; 20(1):85. PubMed ID: 30777030
[TBL] [Abstract][Full Text] [Related]
36. Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer.
Valdés-Mora F; Locke WJ; Bandrés E; Gallego-Ortega D; Cejas P; García-Cabezas MA; Colino-Sanguino Y; Feliú J; Del Pulgar TG; Lacal JC
Oncotarget; 2017 Apr; 8(16):26755-26770. PubMed ID: 28460460
[TBL] [Abstract][Full Text] [Related]
37. A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer.
Rudolph M; Sizemore ST; Lu Y; Teng KY; Basree MM; Reinbolt R; Timmers CD; Leone G; Ostrowski MC; Majumder S; Ramaswamy B
Breast Cancer Res Treat; 2018 Jun; 169(3):457-467. PubMed ID: 29464534
[TBL] [Abstract][Full Text] [Related]
38. A breast cancer prognostic signature predicts clinical outcomes in multiple tumor types.
Wan YW; Qian Y; Rathnagiriswaran S; Castranova V; Guo NL
Oncol Rep; 2010 Aug; 24(2):489-94. PubMed ID: 20596637
[TBL] [Abstract][Full Text] [Related]
39. A network module-based method for identifying cancer prognostic signatures.
Wu G; Stein L
Genome Biol; 2012 Dec; 13(12):R112. PubMed ID: 23228031
[TBL] [Abstract][Full Text] [Related]
40. Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer.
Liu R; Lv QL; Yu J; Hu L; Zhang LH; Cheng Y; Zhou HH
Breast Cancer Res Treat; 2015 Jun; 151(3):607-18. PubMed ID: 25981901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
